DexCom, Inc. (DXCM)
NASDAQ: DXCM · IEX Real-Time Price · USD
130.05
-1.31 (-1.00%)
May 20, 2024, 10:33 AM EDT - Market open
DexCom Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for DexCom stock have an average target of 141.67, with a low estimate of 100 and a high estimate of 165. The average target predicts an increase of 8.94% from the current stock price of 130.05.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 7 | 7 |
Buy | 7 | 7 | 7 | 6 | 6 | 6 |
Hold | 3 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 16 | 15 | 15 | 14 | 15 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Raymond James | Raymond James | Strong Buy Maintains $151 → $160 | Strong Buy | Maintains | $151 → $160 | +23.03% | Apr 26, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $144 → $145 | Strong Buy | Maintains | $144 → $145 | +11.50% | Apr 26, 2024 |
UBS | UBS | Strong Buy Maintains $153 → $163 | Strong Buy | Maintains | $153 → $163 | +25.34% | Apr 10, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $148 → $161 | Strong Buy | Maintains | $148 → $161 | +23.80% | Apr 3, 2024 |
RBC Capital | RBC Capital | Buy Initiates $165 | Buy | Initiates | $165 | +26.87% | Mar 12, 2024 |
Financial Forecast
Revenue This Year
4.41B
from 3.62B
Increased by 21.80%
Revenue Next Year
5.25B
from 4.41B
Increased by 18.99%
EPS This Year
1.78
from 1.30
Increased by 37.24%
EPS Next Year
2.27
from 1.78
Increased by 27.40%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.6B | 5.6B | 6.7B | 7.8B | 9.0B |
Avg | 4.4B | 5.3B | 6.2B | 7.1B | 8.1B |
Low | 4.2B | 4.9B | 5.6B | 6.1B | 6.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 26.6% | 26.1% | 26.9% | 25.6% | 27.2% |
Avg | 21.8% | 19.0% | 17.9% | 14.2% | 14.2% |
Low | 15.3% | 10.9% | 7.3% | -0.8% | -3.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.97 | 2.64 | 3.28 | 3.63 | 4.28 |
Avg | 1.78 | 2.27 | 2.83 | 3.45 | 4.03 |
Low | 1.54 | 1.95 | 2.36 | 3.16 | 3.71 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 51.8% | 47.7% | 44.1% | 28.3% | 24.2% |
Avg | 37.2% | 27.4% | 24.6% | 21.8% | 16.7% |
Low | 18.4% | 9.3% | 3.9% | 11.4% | 7.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.